Ro Khanna (D-CA)
To direct the Chairman of the Joint Chiefs of Staff to conduct a feasibility study on incorporating militarily-relevant applications of emerging biotechnology into wargaming exercises, and for other purposes.
A Democratic bill with 2 Democratic cosponsors · See all 2 cosponsors
Last activity — Referred to the House Committee on Armed Services.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
H.R. 5193 requires the Chairman of the Joint Chiefs of Staff to conduct a study on whether it is feasible and advisable to include emerging biotechnology in wargaming exercises. This review will look at biotechnology that enhances warfighter performance and materials that provide strategic advantages. The Chairman must also consider how adversaries use biotechnology for military purposes. The process involves consulting with combatant command commanders and other stakeholders. A final report with recommendations and a potential update plan must be submitted to the House and Senate Committees on Armed Services within 180 days.
Yes
- Scored +3
Does this put more money into scientific research?
The bill drives the application and study of emerging biotechnology for military use.
- Scored +2
Would business owners be better off under this?
Biotechnology firms may see increased interest and potential contracts from the DoD.
- Scored +2
Does this put more money into medical research?
The bill encourages consultation with biotechnology stakeholders, potentially increasing military-related biotech research.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Improved Warfighter Performance: Section 1(b)(1) focuses on biotechnology-enabled enhancements that could improve the physical and cognitive performance of warfighters.
-
Strategic Advantage: Section 1(b)(2) looks at biotechnology-enabled materials and chemicals intended to provide a strategic advantage on the battlefield.
-
Preparation Against Adversaries: Section 1(b)(3) ensures the military considers how adversaries use biotechnology for military purposes beyond traditional biological weapons.
Potential Negative Impacts for People
- No negative impacts for people are explicitly mentioned in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Education And Technology
- Does this put more money into scientific research? — The bill drives the application and study of emerging biotechnology for military use.
- Demographic And Interest Groups
- Would business owners be better off under this? — Biotechnology firms may see increased interest and potential contracts from the DoD.
- Healthcare
- Does this put more money into medical research? — The bill encourages consultation with biotechnology stakeholders, potentially increasing military-related biotech research.
- 9/8/2025
- Referred to the House Committee on Armed Services.
- 2 Cosponsors added.
- Introduced in House
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Donald DavisDemocrat · North Carolina
John GaramendiDemocrat · California